Invention Grant
- Patent Title: GM3 functionalized nanoparticles
-
Application No.: US15986186Application Date: 2018-05-22
-
Publication No.: US10646451B2Publication Date: 2020-05-12
- Inventor: Bjoern Markus Reinhard , Suryaram Gummuluru
- Applicant: TRUSTEES OF BOSTON UNIVERSITY
- Applicant Address: US MA Boston
- Assignee: TRUSTEES OF BOSTON UNIVERSITY
- Current Assignee: TRUSTEES OF BOSTON UNIVERSITY
- Current Assignee Address: US MA Boston
- Agency: Nixon Peabody LLP
- Main IPC: A61K9/51
- IPC: A61K9/51 ; A61K9/127 ; B82Y5/00 ; A61B5/055 ; G01N33/50 ; A61K47/69 ; A61K47/61 ; A61K47/54

Abstract:
Embodiments disclosed herein relates to ganglioside GM3-containing mixed lipids nanoparticles having an overall size between 60-100 nm, the making thereof and the uses. The nanoparticles selectively targeted to CD169+ expressing cells such as dendritic cells and macrophage. The nanoparticles are endocytosed by the CD169+ expressing cells.
Public/Granted literature
- US20180296492A1 GM3 FUNCTIONALIZED NANOPARTICLES Public/Granted day:2018-10-18
Information query